INSTRUCTIONS
TO AUTHORS
(versão em português)
Revised version - June 2009
Online submission available at: http://submission.scielo.br/index.php/jvb/index
J Vasc Bras is a peer-reviewed quarterly publication of the Brazilian Society of Angiology and Vascular Surgery (Sociedade Brasileira de Angiologia e de Cirurgia Vascular - SBACV). It is directed to vascular surgeons and clinicians and to professionals of related fields, and accepts submissions in Portuguese, English, and Spanish. The mission of the Journal is to select and disseminate high-quality scientific contents concerning original research, novel surgical and diagnostic techniques, and clinical observations in the field of vascular surgery, angiology, and endovascular surgery.
The J Vasc Bras Instructions to Authors follow the recommendations found in the latest version of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of 2008. The complete document is available at www.icmje.org.
GENERAL
INFORMATION
Manuscripts that are not in accordance with the following instructions will be returned to the authors for correction before review by the Editorial Board.
1.
Manuscripts submitted for publication should not have been published
or submitted to other journals in part or in whole.
2.
Materials
published in J Vasc Bras become the property of the Journal and
of SBACV and may not be reproduced elsewhere in part or in whole
without written permission from J Vasc Bras and from SBACV and
without citation of the original source.
3.
Articles including previously published figures should cite the
original source in the corresponding legends. Written permission
must be obtained from the copyright holder (publishing house or
journal).
4.
We recommend that authors keep a copy of the materials submitted
to J Vasc Bras, since they will not be returned to authors.
5.
J Vasc Bras will not consider editorials which were not invited
by the Editor-in-Chief.
6.
Manuscript receipt will be acknowledged via an automatic e-mail
message generated by the submission system (http://submission.scielo.br/index.php/jvb/index).
If the paper is in accordance with the Instructions to Authors
and with the editorial policies of the Journal, it will be reviewed
by two referees appointed by the Editor-in-Chief. Authors and
reviewers remain anonymous throughout the review process. Within
60 days, the authors are informed of either acceptance, rejection,
or the need for revisions in the article, as requested by the
Editorial Board. A decision letter and reviewers' comments will
be e-mailed to the authors. Authors will be requested to return
a revised version of the manuscript within 1 month and to provide
a letter detailing their responses to the reviewers' comments.
Revised manuscripts should clearly indicate changes made to the
text, using red font preferably. Revised manuscripts sill be sent
back to reviewers for reassessment. At this time, a decision will
be made for the acceptance, rejection, or the need for additional
revisions.
7.
A maximum of eight authors per manuscript is allowed. Studies
with more than eight authors should include a statement providing
a reason for the inclusion of each author. In cases of collective
(corporate) authorship, the group should identify the individuals
taking direct responsibility for the manuscript. According to
the Uniform Requirements, edited by the International Committee
of Medical Journal Editors (ICMJE), "authorship credit should
be based on: 1) substantial contributions to conception and design,
acquisition of data, or analysis and interpretation of data; 2)
drafting the article or revising it critically for important intellectual
content; and 3) final approval of the version to be published.
Authors should meet conditions 1, 2, and 3" (http://www.icmje.org/#author).
Inclusion of authors' names whose contributions do not fulfill
these criteria is not warranted. Once manuscript submission has
been acknowledged, it will not be possible to include or change
the list of authors. A supplementary statement describing the
specific contributions of each author to the study should be provided
for each manuscript.
8.
Authors must disclose, by means of a supplementary statement or
along with each author's name, any conflicts of interest that
might bias, or in any way impact the integrity of, the submitted
manuscript. Some examples include publications, public statements
related to the subject of the manuscript, participation in an
industry advisory committee, or other activities related to industry
sources. Authors should use the list below as a criterion for
the statement of potential conflicts of interest:
- to participate in clinical and/or experimental trials supported
by a commercial entity;
- to participate in speaking activities related to industry sources;
- to be a consultant to or director of a commercial entity;
- to participate in an industry advisory committee receiving money
for completion of research;
- to receive grant monies from a commercial entity;
- to be a shareholder of a commercial entity;
- to have a family relationship with owners/directors of a commercial
entity having an interest in the subject of the manuscript;
- to produce scientific reports in journals supported by a commercial
entity;
- to have any financial relationship with people and institutions
that might affect the integrity of the manuscript (e.g., being
an employee, consultant or shareholder of a commercial entity,
receiving honoraria, providing expert testimony, holding patent
rights or having a patent application pending, receiving grants
or other types of financial support).
9.
After being accepted for publication, the article will enter the
production process (press) of J Vasc Bras and will be published
in a future issue, as decided by the Editor-in-Chief. The editorial
office of the Journal will not provide information on the exact
date of publication or on the issue in which the article will
be published, since the contents of each issue are decided exclusively
by the Editor-in-Chief.
10.
A statement concerning approval of the study by the institutional
research ethics committee (or equivalent) should be included with
the manuscript. International authors should state that the manuscript
is in accordance with the Helsinki Declaration and with local
ethical guidelines. Informed consent should be obtained where
appropriate, and this should be clearly indicated in the article.
The authors should keep copies of informed consent forms and other
documents required by the Ethics Committee at the institution
in which the work was carried out. Experimental procedures described
in animal experimental studies should conform to the guidelines
of an ethics committee of a research institute.
11.
J Vasc Bras supports the policy of registration of clinical trials
by the World Health Organization (WHO) and the ICMJE (www.icmje.org),
recognizing the importance of such initiatives for registration
and public access to information on clinical trials. According
to this recommendation, clinical trials should be registered in
one of the Clinical Trials Registries recommended by the WHO and
the ICMJE. Addresses are available at the ICMJE website (e.g.,
www.actr.org.au, www.clinicaltrials.gov, www.ISRCTN.org, www.umin.ac.jp/ctr/index/htm,
and www.trialregister.nl). The clinical trial registration number
should appear below the abstract. All manuscripts resulting from
randomized clinical trials should have a clinical trial registration
number.
12.
Upon acceptance of the manuscript, page proofs (PDF file) are
sent to the corresponding author for approval prior to publication.
Authors should download Acrobat Reader (http://get.adobe.com/br/reader/,
download free of charge) to read the PDF file. Proof corrections
should be limited to typesetting errors. No substantial changes
will be accepted at this stage. Corrected proofs should be returned
within 48 hours of receipt via e-mail (jvascbr@scientific.com.br)
or fax +55 (51) 3012.0575. Once the production process of the
PDF files is completed, the article will be sent to publication
ahead of print at SciELO (http://www.scielo.br/).
TYPES
OF ARTICLES
J
Vasc Bras publishes the following types of articles:
1.
Complete original articles reporting the results of prospective,
experimental, or retrospective studies, as well as articles awarded
in congresses. These articles will be given priority for publication.
They should be composed of: title page, structured abstract (including
the following sections: Background, Objectives, Methods, Results
and Conclusions, with no more than 250 words) and keywords in
English, structured abstract and keywords in Portuguese (if possible),
text (Introduction, Methods, Results, Discussion or equivalent),
acknowledgements (if applicable), references, tables (if applicable),
figure legends (if applicable), and figures (if applicable). Original
articles should not exceed 3,000 words (not including title page,
abstract, tables, figures, and references) and 40 references.
2.
Presentation of novel diagnostic, surgical, and clinical treatments,
provided there are no clear or disguised commercial purposes or
associations with pharmaceutical or medical device companies.
They should be composed of: title page, unstructured abstract
(with no more than 150 words) and keywords in English, unstructured
abstract and keywords in Portuguese (if possible), text, references,
tables (if applicable), figure legends (if applicable), and figures
(if applicable). Innovations should not exceed 3,000 words and
30 references.
3.
Brief communications, i.e., initial or preliminary and partial
results of clinical or surgical studies under development, or
reports on the application of an innovative technique. They should
be composed of: title page, unstructured abstract (with no more
than 150 words) and keywords in English, unstructured abstract
and keywords in Portuguese (if possible), text, references, tables
(if applicable), figure legends (if applicable), and figures (if
applicable). Brief communications should not exceed 1,500 words
and 25 references.
4.
Review articles, including meta-analyses and editorial comments.
They should be composed of: title page, unstructured abstract
(with no more than 150 words) and keywords in English, unstructured
abstract and keywords in Portuguese (if possible), text, references,
tables (if applicable), figure legends (if applicable), and figures
(if applicable). Review articles are allowed to have up to 5,000
words and 100 references.
5.
Well-documented case reports, of great clinical interest. J Vasc
Bras will only accept cases reporting rare entities, pioneer or
innovative treatments, or unexpected results. They should be composed
of: title page, unstructured abstract (including no more than
150 words) and keywords in English, unstructured abstract and
keywords in Portuguese (if possible), text (Introduction, Case
description and Discussion or equivalent), references, figure
legends (if applicable), and figures (if applicable). Case reports
should not exceed 1,500 words and 25 references.
6.
Therapeutic challenge, divided in two parts, as follows: Part
I - Clinical case (follows the format described for case reports),
including images and/or examinations performed, followed by pertinent
questions regarding additional diagnostic means and/or therapeutic
conducts; and Part II - What was done?, describing the conduct
of choice, including procedures (surgical or clinical), additional
examinations, progress of follow-up (if applicable), and conclusions.
They should be composed of: title page, keywords (abstract should
not be included), text (divided in Parts I and II), references,
tables, figure legends (if applicable), and figures (if applicable).
Therapeutic challenges should not exceed 1,500 words and 25 references.
7.
Abstracts of dissertations presented and approved within 12 months
prior to the submission date. They should be composed of: dissertation
title, full names of the author, advisor, and members of the dissertation
committee, date and service/department/program where the dissertation
was developed and presented, abstract, and keywords. Dissertation
abstracts should be structured and have no more than 350 words.
8.
Letters to the Editor concerning editorial subject or published
articles. They should be composed of: title, name of the author,
identification of the article commented, and references (if applicable).
Letters to the Editor should have no more than 350 words.
9.
Special issues, such as annals of congresses, guidelines,
collections of works presented at conferences sponsored by SBACV,
and supplements focusing on specific topics may be organized upon
request to the Editor-in-Chief.
MANUSCRIPT
PREPARATION
All manuscripts should be typed
double-spaced and left aligned, including all sections: title
page, text, references, tables, and figure legends. Manuscripts
should be typed as a Microsoft Word® document, font Times
New Roman, size 12. Do not highlight any parts of the text using
underline or bold. All pages should be numbered consecutively
starting with the title page.
Do not use capital letters to write
names (e.g., SMITH) within the text or in the references. Do not
use periods after the letters in acronyms or abbreviations (AAA
rather than A.A.A.). The spelled-out forms of abbreviations/acronyms
should be given at first mention, followed by the abbreviation/acronym
in parenthesis; thereafter, only the abbreviation/acronym should
be used. Abbreviations used in tables and figures should be explained
in footnotes, even when they have been previously defined in the
text. Names of commercial products should be followed by the trademark
symbol (®); the following information should also be mentioned:
name of manufacturer, city and country where the product was manufactured.
The title page should include the following items: title of the manuscript in English and, if possible, also in Portuguese, and short title in English (up to 50 characters including spaces).
Full names of the authors and co-authors,
their affiliations and details on the corresponding author (name,
address, telephone number, fax, and e-mail) should be informed
in the specific fields of the system (metadata) and removed from
the manuscript document to assure blind peer review. Names of
the institutions in which the work was carried out or to which
the authors are affiliated, as well as congresses where the study
was presented, should not be mentioned in the text either. Such
information can be provided separately and submitted as a supplementary
file. In addition, authors should submit another supplementary
file describing the specific contributions of each author to the
study.
The use of abbreviations and symbols should be avoided in the abstract. References should not be cited in the abstract.
At least three keywords should
be listed below the abstract. Keywords should be in accordance
with the Medical Subject Headings (http://www.nlm.nih.gov/mesh/meshhome.html)
elaborated by the National Library of Medicine.
Tables
Tables (each table typed on a separate
sheet) should be cited in the text and numbered using Arabic numbers
in the order in which they appear in the text, with an explanatory
title and notes if applicable. Tables should be inserted in the
main file, following the references. Use only horizontal borders
before and after the column headers and at the foot of the table.
Do not use vertical borders.
Tables should not duplicate information
previously described in the text. In addition, readers should
be able to understand data provided in tables without reference
to the text. Abbreviations used in tables should be explained
in footnotes.
Figures
All figures should be cited in
the text and numbered using Arabic numbers in the order in which
they appear in the text, with an explanatory legend. All legends
should be listed on the same page at the end of the article. Color
figures are accepted for online publication, but are printed in
black and white; therefore, all figures should be intelligible
in black and white.
Figures should be submitted as
electronic files (only digital images and photographs will be
accepted), in separate files, using extensions .jpg, .gif or .tif,
with a resolution of 300 dpi or higher to enable good-quality
reproduction. Figures should be submitted electronically. If this
is not possible, illustrations should be sent via regular mail.
Scanned photographs will not be accepted; paper photographs should
be submitted via regular mail. Photographs should not allow patient
identification. Graphs should be bidimensional.
If
the resolution of the figure submitted electronically is not considered
adequate for printing, the Journal may contact the authors and
request the submission of a high-resolution version. Identify
all photographs sent via regular mail with a label on the back
of the figure, indicating first author's name and top of the figure
(with an arrow).
Do
not send original X-rays, materials produced in heat-sensitive
paper, or any other medical records. Instead, submit two sets
of good-quality copies of these materials to enable reproduction.
Figures
previously published and included in submitted articles should
cite the original source in the legend and must be accompanied
by written permission from the copyright holder (publishing house
or journal). The authors should keep a copy of the permission
letter(s).
Figures should not duplicate
information previously described in the text. In addition, readers
should be able to understand data provided in figures without
reference to the text. Abbreviations used in figures should be
explained in the legend.
Acknowledgments
In this section, acknowledge the
work of people who contributed intellectually to the manuscript,
but whose contribution does not justify authorship. Also acknowledge
any material support received.
References
All the authors and works cited
in the text should be included in the reference list and vice-versa.
References should be numbered consecutively in the order in which
they appear in the text (not in alphabetical order), identified
by superscript numbers (not by numbers is parenthesis). References
should follow the order in which they appear in the text. Avoid
citing too many references. Select the most relevant references,
and focus on the most recent works (past 5 years).
If possible and relevant, cite
Brazilian and Latin American authors via the following sources:
LILACS (www.bireme.com.br), SciELO (www.scielo.br) and J Vasc
Bras (www.cielo.br/jvb and www.jvascbr.com.br).
Avoid citations that are not easily
available to readers, such as abstracts presented at conferences
or restricted publications. Do not use "personal communications"
as references. Papers that have been accepted for publication
but now yet published may be cited followed by the expression
"in press." For citation of other works by the authors,
select only original journal articles which are related to the
topic under discussion (do not include book chapters or review
articles). The authors are responsible for the accuracy of the
references and should follow the style shown in the examples below.
Journal
articles:
1.
Harvey J, Dardik H, Impeduglia T, Woo D, Debernardis F. Endovascular
management of hepatic artery pseudoaneurysm hemorrhage complicating
pancreaticoduodenectomy. J Vasc Surg. 2006;43:613-7.
2. The UK Small Aneurysm Trial Participants. Mortality results
for randomised controlled trial of early elective surgery or ultrasonographic
surveillance for small abdominal aortic aneurysms. Lancet. 1998;352:1649-55.
3. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital
low molecular-weight heparin prophylaxis against deep venous thrombosis
in patients after elective hip arthroplasty: a systematic review.
Ann Intern Med. 2001;135:858-69.
If
there are more than six authors, cite the first three followed
by "et al." Cite all authors if there are six or fewer.
Note that a period should be inserted after the abbreviated name
of the journal.
Book
chapters:
4.
Rutherford RB. Initial patient evaluation: the vascular consultation.
In: Rutherford RB, editor. Vascular surgery. Philadelphia: WB
Saunders; 2000. p. 1-12.
Journal
articles on the Internet:
5.
Abood S. Quality improvement initiative in nursing homes: the
ANA acts in an advisory role. Am J Nurs [serial on the internet].
2002 Jun [cited 2002 Aug 12];102(6):[approximately 3 p.]. http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
Articles
published on the Internet:
6.
Wantland DJ, Portillo CJ, Holzemer WL, Slaughter R, McGhee EM.
The effectiveness of web-based vs. non-web-based interventions:
a meta-analysis of behavioral change outcomes. J Med Internet
Res. 2004;6(4):e40. http://www.jmir.org/2004/4/e40/. Accessed:
29/11/2004.
Homepage/WebSite:
7.
OncoLink [site on the Internet]. Philadelphia: University of Pennsylvania;
c1994-2006. [updated 2004 Sep 24; cited 2006 Mar 14]. http://cancer.med.upenn.edu/.
Software:
8.
Smallwaters Corporation. Analysis of moment structures: AMOS [software].
Version 5.0.1. Chicago: Smallwaters; 2003.
SUBMISSION
OF THE ARTICLE
Using
the SciELO Submission System (preferred)
Access
J Vasc Bras at SciELO database (http://submission.scielo.br/index.php/jvb/index),
register your login data (login and password) and follow the steps
in order to submit your manuscript.
If
you have any doubts, please contact the editorial office via e-mail
jvascbr@scientific.com.br or at the telephone number +55 (51)
3012.0575.
Jornal
Vascular Brasileiro
Editorial Office
Rua Maranguape, 72, térreo
CEP 90690-380 - Porto Alegre, RS, Brazil
Tel.: +55 (51) 3012.0575
jvascbr@scientific.com.br
